Schiff bases represent a valuable class of organic compounds, synthesized via condensation of primary amines with ketones or aldehydes. They are renowned for possessing innumerable applications in agricultural chemistry, organic synthesis, chemical and biological sensing, coating, polymer and resin industries, catalysis, coordination chemistry, and drug designing. Schiff bases contain imine or azomethine (-C=N-) functional groups which are important pharmacophores for the design and synthesis of lead bioactive compounds. In medicinal chemistry, Schiff bases have attracted immense attention due to their diverse biological activities. This review aims to encompass the recent developments on the antimicrobial activities of Schiff bases. The article summarizes the antibacterial, antifungal, antiviral, antimalarial, and antileishmanial activities of Schiff bases reported since 2011.
Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges of our time. Alarming projections of increasing mortality from resistant infections highlight the urgent need for innovative solutions. While many candidates have shown promise in preliminary studies, they often encounter challenges in terms of efficacy and safety during clinical translation. This review examines cutting-edge approaches to combat AMR, with a focus on engineered antimicrobial peptides, functionalized nanoparticles, and advanced genomic therapies, including Clustered Regularly Interspaced Short Palindromic Repeats-associated proteins (CRISPR-Cas systems) and phage therapy. Recent advancements in these fields are critically analyzed, with a focus on their mechanisms of action, therapeutic potential, and current limitations. Emphasis is given to strategies targeting biofilm disruption and quorum sensing interference, which address key mechanisms of resistance. By synthesizing current knowledge, this work provides researchers with a comprehensive framework for developing next-generation antimicrobials, highlighting the most promising approaches for overcoming AMR through rational drug design and targeted therapies. Ultimately, this review aims to bridge the gap between experimental innovation and clinical application, providing valuable insights for developing effective and resistance-proof antimicrobial agents.
Wound healing is a dynamic process involving distinct phases that are regulated by cellular and molecular interactions. This review explores the fundamental mechanisms involved in wound healing, including the roles of cytokines and growth factors within the local microenvironment, with a particular focus on antimicrobial peptides (AMPs) as immune modulators and therapeutic agents in chronic wounds. Notably, AMPs such as LL-37 have been shown to reduce biofilm density by up to 60%, highlighting their dual role in both modulating host immune responses and combating persistent bacterial infections. It further examines emerging technologies that are transforming the field, extending beyond traditional biological mechanisms to innovations such as smart dressings, 3D bioprinting, AI-driven therapies, regenerative medicine, gene therapy, and organoid models. Additionally, the review addresses strategies to overcome bacterial biofilms and highlights promising approaches including biomaterials, nanomedicine, gene therapy, peptide-loaded nanoparticles, and the application of organoids as advanced platforms for studying and enhancing wound repair.
This study describes the synthesis and characterization of chlorambucil (CLB)-functionalized mesoporous silica nanoparticles (MSNs) for potential application in cancer therapy. The nanoparticles were designed with a diameter between 20 and 50 nm to optimize cellular uptake and avoid rapid clearance from the bloodstream. The synthesis method involved modifying a previously reported technique to reduce particle size. Successful functionalization with CLB was confirmed through various techniques, including Fourier transform infrared spectroscopy (FTIR) and elemental analysis. The cytotoxicity of the CLB-functionalized nanoparticles (MSN@NH2-CLB) was evaluated against human lung adenocarcinoma cells (A549) and colon carcinoma cells (CT26WT). The results suggest significantly higher cytotoxicity of MSN@NH2-CLB compared to unbound CLB, with improved selectivity towards cancer cells over normal cells. This suggests that MSN@NH2-CLB holds promise as a drug delivery system for targeted cancer therapy.
Halophytes are plants adapted to saline soils found in a diversity of environments with varied climatic conditions and high salinity, developing different strategies to complete their life cycle. Their ecological, morphological, physiological and biochemical adaptations allow resistance to the abiotic stresses suffered and the formation of bioactive compounds that give these plants anti-inflammatory, antiparasitic, antimicrobial, antiviral and antioxidant potential properties. Therefore, this study aimed to compile its different biological activities, its nutritional compounds, potential applications for pharmaceutical and food industries, its biotechnological use. Halophytes have vast potential for pharmaceutical industries, as well as being a sustainable alternative in production of animal feed and a viable possibility for replacing the use of table salt and its various applications in human nutrition. It is necessary to invest in new and diversified research highlighted in this study.
Cancer represents a major public health concern, and the therapeutic potential of medicinal plants has been extensively studied as an alternative approach for its treatment. This study evaluated the genotoxic, cytotoxic properties, and selectivity of essential oils from native plants of the Brazilian Cerrado and Pantanal: Cymbopogon citratus, Endlicheria paniculata, Matayba guianensis, and Siparuna guianensis. These species, popular in traditional medicine, were tested for their ability to inhibit the growth of skin (B16-F10), breast (MCF-7), and brain (U251) cancer cells, to assess selective tumor toxicity. The essential oils were analyzed for their cytotoxicity, evaluating their capacity to inhibit cell growth in cancer and normal lines, such as murine fibroblasts (NIH/3T3) and human umbilical vein endothelial cells (HUVEC). Among the oils tested, Matayba guianensis exhibited significant activity against all cancer cell lines studied, while Siparuna. guianensis showed strong inhibitory action on brain cancer cells. Endlicheria paniculata displayed cytotoxicity in both tumor and normal cells, whereas Cymbopogon citratus was toxic only to normal cells. This profile was investigated to assess the oils' ability to preferentially target cancer cells, with Siparuna. guianensis notably displaying high selectivity for brain and breast cancer cells, suggesting safer potential use. Genotoxicity analysis indicated that Siparuna guianensis essential oil lacks mutagenic effects, suggesting an additional safety profile for therapeutic development. Based on these results, Matayba guianensis and Siparuna guianensis oils show promise as anticancer agents, demonstrating selective activity and potential for future therapeutic strategies aimed at cancer treatment.